Epigenetic modifications — particularly histone deacetylation and DNA methylation — alter the expression of neuropeptide Y and opioid peptides in the brain, creating molecular links between stress disorders and alcohol dependence.
Common epigenetic mechanism identifiedHistone deacetylation and DNA methylation alter neuropeptide expression in both stress and alcohol dependence, suggesting these disorders share reversible molecular roots
What the researchers found
The review identifies common epigenetic mechanisms — histone deacetylation and DNA methylation — that regulate neuropeptide expression in both alcoholism and stress disorders. BDNF, CRF, NPY, and opioid peptides (nociceptin, dynorphin) are key molecules whose expression is altered by epigenetic modifications in specific brain regions. Histone deacetylases and methyltransferases have been identified as shared molecular mechanisms driving the interaction between stress and alcohol dependence, making them promising therapeutic targets.
Why it matters
Alcoholism and stress disorders frequently co-occur, but the molecular mechanisms connecting them have been unclear. This review shows that epigenetic changes to neuropeptide genes — particularly NPY and opioid peptides — may be the common thread. This is therapeutically significant because epigenetic modifications are potentially reversible. HDAC inhibitors and other epigenetic drugs could theoretically restore normal neuropeptide function and break the cycle of stress-driven drinking.
How the study worked
Narrative review synthesizing evidence from animal models and human studies on epigenetic mechanisms in alcoholism and stress-related disorders, with focus on chromatin remodeling enzymes and their effects on neuropeptide and growth factor expression in the brain.
What this study cannot tell us
This is a narrative review from 2017, and the field of epigenetics in addiction has continued to evolve. Most evidence comes from animal models, and translation to human epigenetic mechanisms is uncertain. The complexity of epigenetic regulation means that targeting one enzyme (e.g., HDACs) affects many genes beyond the neuropeptides of interest, potentially causing unintended effects. Clinical evidence for epigenetic therapies in alcoholism remains limited.
How to read the evidence
This is a narrative review synthesizing primarily preclinical evidence from animal models. While it provides a compelling mechanistic framework linking epigenetics, neuropeptides, and addiction, most findings await human clinical validation.
When this study was published
Published in 2017, this review laid important groundwork for understanding epigenetic regulation of neuropeptides in addiction. The field has continued to advance, with growing evidence supporting the therapeutic potential of epigenetic approaches.
The bigger picture
The epigenetics of neuropeptide regulation represents a frontier in addiction and mental health research. Traditional pharmacology targets peptide receptors directly, but epigenetic approaches target the upstream regulation of peptide production. This could offer more fundamental and longer-lasting corrections of neuropeptide imbalances. As HDAC inhibitors and other epigenetic therapies advance through clinical development for various conditions, their potential for treating addiction and stress disorders through neuropeptide pathway normalization is an exciting prospect.
Questions still open
- Could targeted epigenetic editing of NPY or opioid peptide genes in specific brain regions treat alcohol dependence?
- Do epigenetic changes to neuropeptide genes persist after prolonged sobriety, explaining relapse vulnerability?
- Would HDAC inhibitors that restore NPY expression be clinically viable for alcoholism treatment?
Common questions
What are epigenetic changes and how do they affect neuropeptides?
Could epigenetic drugs treat alcoholism?
Read the original research
Epigenetic mechanisms of alcoholism and stress-related disorders.
Alcohol (Fayetteville, N.Y.), 60, 7-18
Citation
Palmisano, Martina; Pandey, Subhash C. (2017). Epigenetic mechanisms of alcoholism and stress-related disorders.. Alcohol (Fayetteville, N.Y.), 60, 7-18. https://doi.org/10.1016/j.alcohol.2017.01.001